On Friday, March 27, 2020, AAM and 68 signatories signed on to a letter to President Trump expressing our opposition to proposed “Buy American” requirements that would make it harder for the U.S. government to purchase medicines produced using ingredients from outside the U.S — especially in the middle of a public health emergency. The letter explains, “it is critical that those policies do not restrict access to—or destabilize the supply chain for—currently available pharmaceuticals or medical devices.” Signatories included dozens of patient groups, taxpayer groups and additional non-profits.
Mr President: As you take action through Executive Order or in coordination with Congress, it is critical that those policies do not restrict access to — or destabilize the supply chain for — currently available pharmaceuticals or medical devices.